{"filing":{"accession_number":"0001493152-26-040411","cik":"0001583771","ticker":"CTRVP","company_name":"Hepion Pharmaceuticals, Inc.","form":"8-K","filing_date":"2026-08-27","report_date":"2026-08-25","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1583771/000149315226040411/form8-k.htm"},"events":[{"id":30082,"run_id":27568,"accession_number":"0001493152-26-040411","anchor_item_number":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The filing discloses a private placement of 8,000,000 shares of common stock and 8,000,000 warrants at $0.05 per share for gross proceeds of $400,000, conducted pursuant to Section 4(a)(2) and Rule 506(b) of Regulation D. This is an unregistered sale of equity securities (Item 3.02) that is dilutive to existing shareholders and represents a material capital-raising transaction typical of small-cap issuers in financial need.","company_name":"Hepion Pharmaceuticals, Inc.","ticker":"CTRVP","filing_date":"2026-08-27","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":32585,"accession_number":"0001493152-26-040411","item_number":null,"item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses a private placement of 8,000,000 shares of common stock and 8,000,000 warrants at $0.05 per share for gross proceeds of $400,000, conducted pursuant to Section 4(a)(2) and Rule 506(b) of Regulation D. This is an unregistered sale of equity securities (Item 3.02) that is dilutive to existing shareholders and represents a material capital-raising transaction typical of small-cap issuers in financial need.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-27T20:32:05.425252+00:00","company_name":"Hepion Pharmaceuticals, Inc.","ticker":"CTRVP","filing_date":"2026-08-27"}]}